Search results for "PYRIDINE"
showing 10 items of 2516 documents
CCDC 1409981: Experimental Crystal Structure Determination
2015
Related Article: Paulina I. Hidalgo, Sergio Leal, Claudio A. Jiménez, Esteban Vöhringer-Martinez, Bárbara Herrera, Jorge Pasán, Catalina Ruiz-Pérez, Duncan W. Bruce|2016|CrystEngComm|18|42|doi:10.1039/C5CE02154E
CCDC 620726: Experimental Crystal Structure Determination
2006
Related Article: C.Peifer, M.Abadleh, D.Schollmeyer, S.Laufer|2006|Acta Crystallogr.,Sect.E:Struct.Rep.Online|62|o3647|doi:10.1107/S1600536806029448
CCDC 2068114: Experimental Crystal Structure Determination
2021
Related Article: Shilin Yu, Jas S. Ward, Khai-Nghi Truong, Kari Rissanen|2021|Angew.Chem.,Int.Ed.|60|20739|doi:10.1002/anie.202108126
CCDC 2027280: Experimental Crystal Structure Determination
2020
Related Article: Christian Schumacher, Hannah Fergen, Rakesh Puttreddy, Khai-Nghi Truong, Torsten Rinesch, Kari Rissanen, Carsten Bolm|2020|Org.Chem.Front.|7|3896|doi:10.1039/D0QO01139H
CCDC 2027296: Experimental Crystal Structure Determination
2020
Related Article: Christian Schumacher, Hannah Fergen, Rakesh Puttreddy, Khai-Nghi Truong, Torsten Rinesch, Kari Rissanen, Carsten Bolm|2020|Org.Chem.Front.|7|3896|doi:10.1039/D0QO01139H
CCDC 1441505: Experimental Crystal Structure Determination
2018
Related Article: Michael G. S. Londesborough, Jiří Dolanský, Tomáš Jelínek, John D. Kennedy, Ivana Císařová, Robert D. Kennedy, Daniel Roca-Sanjuán, Antonio Francés-Monerris, Kamil Lang, William Clegg|2018|Dalton Trans.|47|1709|doi:10.1039/C7DT03823B
CCDC 2026029: Experimental Crystal Structure Determination
2020
Related Article: Carmen Ramírez de Arellano, Rosa Adam, Rafael Ballesteros-Garrido, Belen Abarca, Rafael Ballesteros, Ibon Alcorta, José Elguero, Emilio Escrivà|2020|CrystEngComm|22|6979|doi:10.1039/D0CE01272F
CCDC 799866: Experimental Crystal Structure Determination
2011
Related Article: R.Ballesteros-Garrido, L.Bonnafoux, F.Blanco, R.Ballesteros, F.R.Leroux, B.Abarca, F.Colobert, I.Alkorta, J.Elguero|2011|Dalton Trans.|40|1387|doi:10.1039/c0dt01183e
New Tripentone Analogs with Antiproliferative Activity
2017
Tripentones represent an interesting class of compounds due to their significant cytotoxicity against different human tumor cells in the submicro-nanomolar range. New tripentone analogs, in which a pyridine moiety replaces the thiophene ring originating the fused azaindole system endowed with anticancer activity viz 8H-thieno[2,3-b]pyrrolizinones, were efficiently synthesized in four steps with fair overall yields (34–57%). All tripentone derivatives were tested in the range of 0.1–100 μM for cytotoxicity against two human tumor cell lines, HCT-116 (human colorectal carcinoma) and MCF-7 (human breast cancer). The most active derivative, with GI50 values of 4.25 µM and 20.73 µM for HCT-116 a…
Pyrithione-based ruthenium complexes as inhibitors of aldo-keto reductase 1C enzymes and anticancer agents.
2016
Four ruthenium complexes of clinically used zinc ionophore pyrithione and its oxygen analog 2-hydroxypyridine N-oxide were prepared and evaluated as inhibitors of enzymes of the aldo–keto reductase subfamily 1C (AKR1C). A kinetic study assisted with docking simulations showed a mixed type of inhibition consisting of a fast reversible and a slow irreversible step in the case of both organometallic compounds 1A and 1B. Both compounds also showed a remarkable selectivity towards AKR1C1 and AKR1C3 which are targets for breast cancer drug design. The organoruthenium complex of ligand pyrithione as well as pyrithione itself also displayed toxicity on the hormone-dependent MCF-7 breast cancer cell…